300639 凯普生物
已收盘 12-25 15:00:00
资讯
新帖
简况
凯普生物(300639)12月10日股东户数3.49万户,较上期减少2.02%
证券之星 · 12-12
凯普生物(300639)12月10日股东户数3.49万户,较上期减少2.02%
凯普生物(300639)11月29日股东户数3.56万户,较上期减少2.99%
证券之星 · 12-11
凯普生物(300639)11月29日股东户数3.56万户,较上期减少2.99%
凯普生物(300639)11月29日股东户数3.56万户,较上期减少2.99%
证券之星 · 12-03
凯普生物(300639)11月29日股东户数3.56万户,较上期减少2.99%
凯普生物(300639)11月20日股东户数3.67万户,较上期增加5.58%
证券之星 · 11-26
凯普生物(300639)11月20日股东户数3.67万户,较上期增加5.58%
凯普生物最新公告:签署7000万元股票回购贷款合同
证券之星 · 11-19
凯普生物最新公告:签署7000万元股票回购贷款合同
凯普生物:签署7000万元股票回购贷款合同
美港电讯 · 11-19
凯普生物:签署7000万元股票回购贷款合同
11月18日凯普生物(300639)龙虎榜数据:机构净买入1150.78万元,北向资金净买入181.42万元
证券之星 · 11-18
11月18日凯普生物(300639)龙虎榜数据:机构净买入1150.78万元,北向资金净买入181.42万元
凯普生物获得实用新型专利授权:“一种多通道样本载架”
证券之星 · 11-16
凯普生物获得实用新型专利授权:“一种多通道样本载架”
凯普生物(300639.SZ)拟斥5000万元至1亿元实施回购 回购价不超9元/股
智通财经 · 11-14
凯普生物(300639.SZ)拟斥5000万元至1亿元实施回购 回购价不超9元/股
凯普生物最新公告:拟以5000万元至1亿元回购股份
证券之星 · 11-14
凯普生物最新公告:拟以5000万元至1亿元回购股份
凯普生物(300639)10月31日股东户数3.48万户,较上期减少0.76%
证券之星 · 11-05
凯普生物(300639)10月31日股东户数3.48万户,较上期减少0.76%
凯普生物:10月30日召开分析师会议,太平洋证券、中银资产管理有限公司等多家机构参与
证券之星 · 10-31
凯普生物:10月30日召开分析师会议,太平洋证券、中银资产管理有限公司等多家机构参与
凯普生物(300639)2024年三季报简析:净利润减252.19%,三费占比上升明显
证券之星 · 10-31
凯普生物(300639)2024年三季报简析:净利润减252.19%,三费占比上升明显
图解凯普生物三季报:第三季度单季净利润同比减475.54%
证券之星 · 10-30
图解凯普生物三季报:第三季度单季净利润同比减475.54%
凯普生物(300639.SZ)发布前三季度业绩,净亏损2.62亿元
智通财经 · 10-29
凯普生物(300639.SZ)发布前三季度业绩,净亏损2.62亿元
凯普生物(300639)10月10日股东户数3.55万户,较上期减少6.81%
证券之星 · 10-16
凯普生物(300639)10月10日股东户数3.55万户,较上期减少6.81%
凯普生物(300639.SZ)子公司磷酸氯喹凝胶获批开展临床试验
智通财经 · 09-20
凯普生物(300639.SZ)子公司磷酸氯喹凝胶获批开展临床试验
凯普生物最新公告:全资子公司获得“磷酸氯喹凝胶”药物临床试验批准通知书
证券之星 · 09-20
凯普生物最新公告:全资子公司获得“磷酸氯喹凝胶”药物临床试验批准通知书
凯普生物最新公告:全资子公司取得医疗器械注册证书
证券之星 · 09-10
凯普生物最新公告:全资子公司取得医疗器械注册证书
凯普生物(300639.SZ)子公司取得一项医疗器械注册证
智通财经 · 09-10
凯普生物(300639.SZ)子公司取得一项医疗器械注册证
暂无数据
公司概况
公司名称:
广东凯普生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2017-04-12
主营业务:
广东凯普生物科技股份有限公司主营业务为诊断产品的研发、生产及销售,并提供相关的检测服务。公司的主要产品是第三方医学实验室检验服务和核酸检测试剂及仪器。公司建立有广东省人乳头状瘤病毒(HPV)相关疾病分子诊断工程技术研究开发中心、广东省省级企业技术中心、博士后科研工作站、广东省博士工作站、博士科研工作站、广东省传染病和遗传病体外诊断试剂工程中心等研发创新平台。
发行价格:
18.39
{"stockData":{"symbol":"300639","market":"SZ","secType":"STK","nameCN":"凯普生物","latestPrice":6.02,"timestamp":1735110237000,"preClose":6.11,"halted":0,"volume":6579118,"delay":0,"floatShares":635000000,"shares":647000000,"eps":-0.4541,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.09,"latestTime":"12-25 15:00:00","open":6.15,"high":6.24,"low":5.96,"amount":39854900,"amplitude":0.0458,"askPrice":6.02,"askSize":34,"bidPrice":6.01,"bidSize":28,"shortable":0,"etf":0,"ttmEps":-0.4541,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735176600000},"adr":0,"adjPreClose":6.11,"symbolType":"stock","openAndCloseTimeList":[[1735090200000,1735097400000],[1735102800000,1735110000000]],"highLimit":6.72,"lowLimit":5.5,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":646500674,"pbRate":0.88,"roa":"--","roe":"--","epsLYR":0.25,"committee":0.41043,"marketValue":3892000000,"floatMarketCap":3824000000,"peRate":-13.256991,"changeRate":-0.0147,"turnoverRate":0.0104,"status":1},"requestUrl":"/m/hq/s/300639/tweets","defaultTab":"tweets","newsList":[{"id":"2490729578","title":"凯普生物(300639)12月10日股东户数3.49万户,较上期减少2.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729578","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490729578?lang=zh_cn&edition=full","pubTime":"2024-12-12 17:06","pubTimestamp":1733994387,"startTime":"0","endTime":"0","summary":"证券之星消息,近日凯普生物披露,截至2024年12月10日公司股东户数为3.49万户,较11月29日减少718.0户,减幅为2.02%。在医疗器械行业个股中,凯普生物股东户数高于行业平均水平,截至12月10日,医疗器械行业平均股东户数为2.04万户。从股价来看,2024年11月29日至2024年12月10日,凯普生物区间涨幅为1.94%,在此期间股东户数减少718.0户,减幅为2.02%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200027400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0239","BK0132","300639","BK0046"],"gpt_icon":0},{"id":"2490523835","title":"凯普生物(300639)11月29日股东户数3.56万户,较上期减少2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490523835","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490523835?lang=zh_cn&edition=full","pubTime":"2024-12-11 17:05","pubTimestamp":1733907932,"startTime":"0","endTime":"0","summary":"证券之星消息,近日凯普生物披露,截至2024年11月29日公司股东户数为3.56万户,较11月20日减少1098.0户,减幅为2.99%。在医疗器械行业个股中,凯普生物股东户数高于行业平均水平,截至11月29日,医疗器械行业平均股东户数为2.04万户。从股价来看,2024年11月20日至2024年11月29日,凯普生物区间跌幅为5.49%,在此期间股东户数减少1098.0户,减幅为2.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121100028052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0132","300639","BK0239","BK0042"],"gpt_icon":0},{"id":"2488464995","title":"凯普生物(300639)11月29日股东户数3.56万户,较上期减少2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488464995","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488464995?lang=zh_cn&edition=full","pubTime":"2024-12-03 17:08","pubTimestamp":1733216915,"startTime":"0","endTime":"0","summary":"证券之星消息,近日凯普生物披露,截至2024年11月29日公司股东户数为3.56万户,较11月20日减少1098.0户,减幅为2.99%。在医疗器械行业个股中,凯普生物股东户数高于行业平均水平,截至11月29日,医疗器械行业平均股东户数为2.05万户。从股价来看,2024年11月20日至2024年11月29日,凯普生物区间跌幅为5.49%,在此期间股东户数减少1098.0户,减幅为2.99%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120300029779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0239","BK0132","300639","BK0046"],"gpt_icon":0},{"id":"2486902652","title":"凯普生物(300639)11月20日股东户数3.67万户,较上期增加5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486902652","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486902652?lang=zh_cn&edition=full","pubTime":"2024-11-26 17:04","pubTimestamp":1732611885,"startTime":"0","endTime":"0","summary":"证券之星消息,近日凯普生物披露,截至2024年11月20日公司股东户数为3.67万户,较10月31日增加1939.0户,增幅为5.58%。在医疗器械行业个股中,凯普生物股东户数高于行业平均水平,截至11月20日,医疗器械行业平均股东户数为2.05万户。从股价来看,2024年10月31日至2024年11月20日,凯普生物区间涨幅为17.94%,在此期间股东户数增加1939.0户,增幅为5.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600028688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0132","300639","BK0239","BK0042"],"gpt_icon":0},{"id":"2484929269","title":"凯普生物最新公告:签署7000万元股票回购贷款合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2484929269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484929269?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:00","pubTimestamp":1732006842,"startTime":"0","endTime":"0","summary":"凯普生物公告,公司与中国银行股份有限公司潮州分行签署了《上市公司股票回购/增持业务专项借款合同》。合同主要内容包括:借款金额为7,000万元,借款期限为12个月,自实际提款日起算;借款用途为专项用于证券代码300639股票回购。公司将根据市场情况在回购期限内择机实施本次回购计划,并按照相关法律法规的规定及时履行信息披露义务。本次签署股票回购专项贷款合同不构成关联交易,亦不构成重大资产重组,不会对公司当年的经营业绩产生重大影响。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900027132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0239","BK0132","300639"],"gpt_icon":0},{"id":"2484944259","title":"凯普生物:签署7000万元股票回购贷款合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2484944259","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484944259?lang=zh_cn&edition=full","pubTime":"2024-11-19 16:52","pubTimestamp":1732006363,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1497734951.SGD","BK0012","LU2097828714.EUR","LU1515016050.SGD","SG9999006597.SGD","LU1634259557.SGD","03143","LU1522347837.USD","BK0132","601988","SG9999001093.SGD","LU1051769294.HKD","LU1224444064.USD","BK0015","LU0307460666.USD","03988","LU0588546209.SGD","LU1051768304.USD","LU1634259391.SGD","BK1521","BK1560","LU2097828557.USD","BK0046","BK0278","LU0072462343.USD","BK0042","BK0188","LU0348805143.USD","LU1282651048.USD","BK0028","LU0651946864.USD","IE00BQJZWZ67.USD","IE00BWDBJ730.SGD","LU0293314216.USD","LU1497733557.USD","LU0651947912.USD","LU2097828474.EUR","BK0183","LU1497733631.SGD","BK0239","BK1231","LU1282651121.HKD","LU1048588211.SGD","IE00B19Z5X02.USD","LU2097828631.EUR","300639","LU2097828805.USD"],"gpt_icon":0},{"id":"2484645032","title":"11月18日凯普生物(300639)龙虎榜数据:机构净买入1150.78万元,北向资金净买入181.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484645032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484645032?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:14","pubTimestamp":1731921248,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2024年11月18日公布的交易公开信息显示,凯普生物因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2024年11月18日收盘,凯普生物报收于7.38元,上涨18.27%,换手率11.47%,成交量72.86万手,成交额5.03亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入1150.78万元,北向资金合计净买入181.42万元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800022189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0132","BK0046","300639","BK0239"],"gpt_icon":0},{"id":"2483258414","title":"凯普生物获得实用新型专利授权:“一种多通道样本载架”","url":"https://stock-news.laohu8.com/highlight/detail?id=2483258414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483258414?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:36","pubTimestamp":1731699392,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示凯普生物新获得一项实用新型专利授权,专利名为“一种多通道样本载架”,专利申请号为CN202420254963.3,授权日为2024年11月8日。今年以来凯普生物新获得专利授权29个,较去年同期减少了23.68%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111600007974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0239","BK0132","300639"],"gpt_icon":0},{"id":"2483087162","title":"凯普生物(300639.SZ)拟斥5000万元至1亿元实施回购 回购价不超9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483087162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483087162?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:21","pubTimestamp":1731586886,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯普生物(300639.SZ)公告,公司拟使用自有资金和银行专项回购贷款资金以集中竞价交易方式回购公司部分股份,资金总额不低于人民币5000万元(含),不超过人民币1亿元(含),回购股份的价格不超过人民币9.00元/股(含)。回购股份的实施期限自公司董事会审议通过本回购股份方案之日起不超过3个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","BK0239","300639","BK0132","BK0046"],"gpt_icon":0},{"id":"2483871641","title":"凯普生物最新公告:拟以5000万元至1亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483871641","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483871641?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:20","pubTimestamp":1731586818,"startTime":"0","endTime":"0","summary":"凯普生物公告,公司拟使用自有资金和银行专项回购贷款资金以集中竞价交易方式回购公司部分股份。回购股份的种类为公司已发行的人民币普通股(A股)股票,回购股份的用途为维护公司价值及股东权益。回购价格不超过人民币9.00元/股(含),回购资金总额为不低于人民币5,000万元(含),不超过人民币10,000万元(含)。回购股份的实施期限为自公司董事会审议通过本回购股份方案之日起不超过3个月。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400034247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","BK0132","BK0046","300639"],"gpt_icon":0},{"id":"2481218275","title":"凯普生物(300639)10月31日股东户数3.48万户,较上期减少0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481218275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481218275?lang=zh_cn&edition=full","pubTime":"2024-11-05 17:02","pubTimestamp":1730797363,"startTime":"0","endTime":"0","summary":"证券之星消息,近日凯普生物披露,截至2024年10月31日公司股东户数为3.48万户,较10月18日减少266.0户,减幅为0.76%。在医疗器械行业个股中,凯普生物股东户数高于行业平均水平,截至10月31日,医疗器械行业平均股东户数为2.03万户。从股价来看,2024年10月18日至2024年10月31日,凯普生物区间跌幅为3.37%,在此期间股东户数减少266.0户,减幅为0.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500028434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0132","BK0239","300639"],"gpt_icon":0},{"id":"2479103127","title":"凯普生物:10月30日召开分析师会议,太平洋证券、中银资产管理有限公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2479103127","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479103127?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:06","pubTimestamp":1730344019,"startTime":"0","endTime":"0","summary":"年初至三季度末,公司累计计提减值 4.03 亿元,其中计提信用减值损失 3.82 亿元,计提资产减值损失 0.21亿元。答:目前全国已有 11个省医保局明确 HPV集采落地,共有 9个省份已公示医院的报量数据。根据 9 个省份的医院报量数据,与公司 HPV 检测产品有关的报量情况良好,正在陆续完成合同签订工作。2024年前三季度,公司 HPV产品销量与去年同期基本持平。公司大部分应收账款是内地各省市、地方政府及公立医疗机构拖欠的款项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100019220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1258","BK0201","BK0132","BK0028","BK1542","09983","BK0183","300639","BK0046","BK0042","BK0012","BK0188","BK0276","BK0239","601099","BK1229","161027","BK0077"],"gpt_icon":0},{"id":"2479087760","title":"凯普生物(300639)2024年三季报简析:净利润减252.19%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2479087760","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479087760?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:42","pubTimestamp":1730328173,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期凯普生物发布2024年三季报。截至本报告期末,公司营业总收入6.1亿元,同比下降28.26%,归母净利润-2.62亿元,同比下降252.19%。本报告期凯普生物三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达90.67%。去年的净利率为6.2%,算上全部成本后,公司产品或服务的附加值一般。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100009468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639"],"gpt_icon":0},{"id":"2479590237","title":"图解凯普生物三季报:第三季度单季净利润同比减475.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479590237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479590237?lang=zh_cn&edition=full","pubTime":"2024-10-30 01:49","pubTimestamp":1730224149,"startTime":"0","endTime":"0","summary":"证券之星消息,凯普生物2024年三季报显示,公司主营收入6.1亿元,同比下降28.26%;归母净利润-2.62亿元,同比下降252.19%;扣非净利润-2.7亿元,同比下降276.98%;其中2024年第三季度,公司单季度主营收入2.01亿元,同比下降17.47%;单季度归母净利润-1.85亿元,同比下降475.54%;单季度扣非净利润-1.85亿元,同比下降466.27%;负债率10.04%,投资收益880.97万元,财务费用-1410.94万元,毛利率53.81%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000001403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639"],"gpt_icon":0},{"id":"2479401215","title":"凯普生物(300639.SZ)发布前三季度业绩,净亏损2.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479401215","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479401215?lang=zh_cn&edition=full","pubTime":"2024-10-29 20:31","pubTimestamp":1730205096,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯普生物(300639.SZ)发布2024年三季度报告,该公司前三季度营业收入为6.1亿元,同比减少28.26%。归属于上市公司股东的净亏损为2.62亿元。归属于上市公司股东的扣除非经常性损益的净亏损为2.7亿元。基本每股亏损为0.4068元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1202828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300639","BK0132","BK0046","BK0239","BK0042"],"gpt_icon":0},{"id":"2475958932","title":"凯普生物(300639)10月10日股东户数3.55万户,较上期减少6.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475958932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475958932?lang=zh_cn&edition=full","pubTime":"2024-10-16 17:04","pubTimestamp":1729069452,"startTime":"0","endTime":"0","summary":"证券之星消息,近日凯普生物披露,截至2024年10月10日公司股东户数为3.55万户,较9月30日减少2594.0户,减幅为6.81%。在医疗器械行业个股中,凯普生物股东户数高于行业平均水平,截至10月10日,医疗器械行业平均股东户数为2.0万户。从股价来看,2024年9月30日至2024年10月10日,凯普生物区间跌幅为4.13%,在此期间股东户数减少2594.0户,减幅为6.81%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101600026516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","BK0132","BK0046","300639"],"gpt_icon":0},{"id":"2468475036","title":"凯普生物(300639.SZ)子公司磷酸氯喹凝胶获批开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2468475036","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468475036?lang=zh_cn&edition=full","pubTime":"2024-09-20 20:14","pubTimestamp":1726834473,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯普生物(300639.SZ)发布公告,近日,公司全资子公司广州凯普生物科技有限公司收到国家药品监督管理局核准签发的关于“磷酸氯喹凝胶”的《药物临床试验批准通知书》。磷酸氯喹凝胶是一款针对HPV病毒感染的治疗药物。本次是磷酸氯喹凝胶新增高危型HPV病毒感染适应症的临床试验获批。经查询,目前国内外尚无同类产品获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","03347","BK0042","BK1141","BK0239","BK1583","300639","BK0132","BK0046"],"gpt_icon":0},{"id":"2468471826","title":"凯普生物最新公告:全资子公司获得“磷酸氯喹凝胶”药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2468471826","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468471826?lang=zh_cn&edition=full","pubTime":"2024-09-20 20:10","pubTimestamp":1726834224,"startTime":"0","endTime":"0","summary":"凯普生物公告,全资子公司广州凯普生物科技有限公司收到国家药品监督管理局关于“磷酸氯喹凝胶”的《药物临床试验批准通知书》,同意该产品开展针对高危型HPV病毒感染的临床试验。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092000036141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0042","BK0239","300639","BK1141","BK1583","03347","BK0132","BK0046"],"gpt_icon":0},{"id":"2466000489","title":"凯普生物最新公告:全资子公司取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2466000489","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466000489?lang=zh_cn&edition=full","pubTime":"2024-09-10 17:10","pubTimestamp":1725959459,"startTime":"0","endTime":"0","summary":"凯普生物公告,全资子公司广州凯普医药科技有限公司近日取得国家药品监督管理局颁发的《中华人民共和国医疗器械注册证(体外诊断试剂)》。产品名称为SOX1和PAX1基因甲基化检测试剂盒(PCR-荧光探针法),用于体外定性检测人宫颈脱落细胞中的SOX1和PAX1基因的甲基化状态,适用于12种高危HPV基因型检测阳性的30岁及以上女性人群,帮助识别是否需要进行阴道镜检查。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000027997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1222","300639","BK0132","09997","BK1583","BK1100","BK0239","BK1574","BK0046","159883","09996","BK0042"],"gpt_icon":0},{"id":"2466489619","title":"凯普生物(300639.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2466489619","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466489619?lang=zh_cn&edition=full","pubTime":"2024-09-10 17:01","pubTimestamp":1725958914,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯普生物(300639.SZ)公告,公司全资子公司广州凯普医药科技有限公司近日取得国家药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》,产品名称为:SOX1和PAX1基因甲基化检测试剂盒(PCR-荧光探针法)。公告显示,公司自主研发的SOX1和PAX1基因甲基化检测试剂盒(PCR-荧光探针法)采用DNA甲基化特异性PCR检测技术,检测宫颈脱落细胞中两个抑癌基因SOX1和PAX1的甲基化状态,能把感染HPV阳性的患者进一步分流,对患者是否需要进行阴道镜检查进行指导,为宫颈癌的发生、发展提供动态指标,更方便准确地辅助临床诊断和采取对应干预治疗措施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1181414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300639","BK1583","BK1222","BK0132","BK1574","BK1100","09997","BK0042","159883","BK0046","BK0239","09996"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-04-12","address":"广东省潮州市湘桥区经济开发区试验区北片高新区D5-3-3-4小区","stockEarnings":[{"period":"1week","weight":-0.0549},{"period":"1month","weight":-0.1173},{"period":"3month","weight":0.0808},{"period":"6month","weight":0.3087},{"period":"1year","weight":-0.3355},{"period":"ytd","weight":-0.3483}],"companyName":"广东凯普生物科技股份有限公司","boardCode":"AI0027","perCapita":"18201股","boardName":"医药制造业","registeredCapital":"64650万元","compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":0.0397},{"period":"3month","weight":0.1308},{"period":"6month","weight":0.1435},{"period":"1year","weight":0.1706},{"period":"ytd","weight":0.1406}],"survey":" 广东凯普生物科技股份有限公司主营业务为诊断产品的研发、生产及销售,并提供相关的检测服务。公司的主要产品是第三方医学实验室检验服务和核酸检测试剂及仪器。公司建立有广东省人乳头状瘤病毒(HPV)相关疾病分子诊断工程技术研究开发中心、广东省省级企业技术中心、博士后科研工作站、广东省博士工作站、博士科研工作站、广东省传染病和遗传病体外诊断试剂工程中心等研发创新平台。","serverTime":1735171374872,"listedPrice":18.39,"stockholders":"34897人(较上一季度减少2.02%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯普生物(300639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯普生物(300639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯普生物,300639,凯普生物股票,凯普生物股票老虎,凯普生物股票老虎国际,凯普生物行情,凯普生物股票行情,凯普生物股价,凯普生物股市,凯普生物股票价格,凯普生物股票交易,凯普生物股票购买,凯普生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯普生物(300639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯普生物(300639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}